Mersana Therapeutics Investor Relations Material

Mersana Therapeutics Inc. is a biotechnology company specializing in the development of innovative antibody-drug conjugates (ADCs) for cancer treatment. The company's proprietary ADC platforms are designed to deliver targeted therapies by combining antibodies with potent anti-cancer agents, aiming to improve efficacy and reduce side effects. Mersana's approach allows for enhanced drug delivery and customization, addressing various types of cancer. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.